ID   SNU-2564
AC   CVCL_YI75
DR   cancercelllines; CVCL_YI75
DR   KCLB; 02564
DR   Wikidata; Q98132758
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 58 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02564; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
RX   PubMed=31688591; DOI=10.1097/MPA.0000000000001420; PMCID=PMC6867661;
RA   Kim S.-C., Shin Y.-K., Kim S.-W., Seo H.-Y., Kwon W., Kim H., Han Y.,
RA   Lee J.-O., Jang J.-Y., Ku J.-L.;
RT   "Establishment and characterization of 10 human pancreatic cancer cell
RT   lines including a HER2 overexpressed cell line.";
RL   Pancreas 48:1285-1293(2019).
//